Sequenom Shares Jump 62 Percent in Strong February for GWDN Index | GenomeWeb

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Shares of Sequenom rose 62 percent during the month of February — boosted by the launch of a couple of molecular diagnostic tests — to lead all of the 33 stocks in the GenomeWeb Daily News Index.

The San Diego-based firm was one of four stocks in the Index that gained more than 20 percent for the month. The others included Affymetrix (+38 percent), Millipore (+37 percent), and Caliper Life Sciences (+23 percent).

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PLOS this week: genetic study of breast cancer in Egyptian families, mutations linked to cleft lip and palate, and more.

Council Bluffs, Iowa, schools are encouraging more girls to pursue STEM courses, according to the Associated Press.

Because of new open-access requirements, Gates Foundation-funded researchers can't publish in some top journals, Nature News reports.

In Science this week: deletion of one microRNA allows pluripotent stem cells to form embryonic and non-embryonic lineages, and more.